Introduction

Target Audience

Accreditation Information

Educational Objectives

How to Obtain CME Credit

Faculty

Disclosure Information

THE MYCOLOGY INITIATIVE IS AN ACCREDITED EDUCATIONAL program designed and implemented by members of the International Immunocompromised Host Society (ICHS). The goal of this program is to provide leading-edge information in the area of medical mycology to physicians and other healthcare providers. The program has been designed to address important issues about fungal disease such as epidemiology, pathogenesis, diagnosis, prevention, and treatment of the immunocompromised patient. Preeminent leaders in medical mycology will develop content areas as monographs and slide/ lecture sets that will be made available to you at regular intervals.

Opportunistic Fungi in the Immunocompromised Patient, the first monograph in this series, was an introduction to the general topic of fungal infections in high-risk patients. The second monograph, Opportunistic Fungi in Cancer and Hematopoietic Stem-Cell Transplant Patients: Diagnosis and Management Strategies, was an in-depth discussion of the specialized area of fungal infection in the cancer Patient, specifically patients undergoing hematopoietic stem-cell transplantation (HSCT). This third monograph is a more in-depth discussion of fungal infections in solid organ transplant recipients.

This publication is specifically designed for practicing physicians specializing in infectious diseases and/or solid organ transplantation, physicians in training, and any other healthcare professional involved in the care of solid organ transplant patients.

This activity has been implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Imedex^®, Inc. and the International Immunocompromised Host Society.

Imedex, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Imedex designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent on the activity.

Upon completion of this activity, the participant should be able to:

Provide an overview of common fungal pathogens causing clinically significant infections in solid organ transplant patients.

Discuss the relationship between the infecting fungal organism and type of organ transplanted and time after transplantation.

Understand current modalities and rationales for treatment of fungal infections in solid organ transplant patients.

Up   

To successfully complete this activity, Imedex requires that you read the objectives, read the monograph, take the post test on pages 38-40, fill out the evaluation on page 41, and mail or fax the completed forms back to Imedex. Estimated time to complete this activity is 2 hours. Credits will only be awarded for completion of post test (score > 70%) and return of the completed evaluation form. All documentation should be received no later than one year from release date.

Release date: October 22, 2004.
Expiration date: October 22, 2005.

Carol A. Kauffman, MD

Chief, Infectious Diseases, VA Medical Center Professor of Internal Medicine
University of Michigan Medical School
Ann Arbor, Michigan

Jay A. Fishman, MD

Director, Transplant Infectious Disease & Compromised Host Program
Massachusetts General Hospital
Boston, Massachusetts

Bernard Kubak, MD

Professor of Medicine & Infectious Disease
UCLA School of Medicine-Infectious Disease
Los Angeles, California

Thomas F. Patterson, MD, FACP

Associate Professor of Medicine
University of Texas Health Science Center
San Antonio, Texas

John R. Perfect, MD

Associate Professor of Microbiology
Duke University Medical Center
Durham, North Carolina

Up   

As an accredited provider of Continuing Medical Education, Imedex^®, Inc. is required to ask speakers to disclose any real or apparent conflict of interest they may have related to the content of their presentation(s). The existence of commercial or financial interests of speakers related to the subject matter of their presentation(s) should not be construed as implying bias or decreasing the value of their presentation(s). However, disclosure should help the participant form their own judgments. The following information was disclosed.